Assisted living, memory care operators elevate dementia caregiving
By
Kimberly Bonvissuto
Jan 03, 2024
Two senior living communities have launched initiatives to elevate care for residents living with dementia and other cognitive issues.
Dementia-focused programming highlights individuals over disease
By
Kimberly Bonvissuto
Jul 15, 2022
Care for people living with Alzheimer’s disease and other dementias is getting a boost from training and education programs designed to highlight the individuals and not the disease.
When it comes to dementia care, words matter, experts say
By
Kimberly Bonvissuto
Feb 27, 2024
Words matter, especially in the field of dementia care, according to a panel of experts who debated the effects of language used in the senior living industry, particularly surrounding memory care.
Increase in antipsychotic prescribing for residents with dementia raises concerns
By
Kimberly Bonvissuto
Jan 09, 2024
The persistence of a pandemic-associated increase in antipsychotic, antidepressant and anticonvulsant medication use in assisted living residents — and a greater increase in antipsychotic use in dementia...
Aegis Living, SLR recognized for achieving elevated memory care standards
By
Kimberly Bonvissuto
Feb 26, 2024
Two assisted living and memory care providers have earned certifications for meeting elevated standards of care for people living with dementia.
Memory care, falls prevention studies secure nearly $35 million in grant funding
By
Kimberly Bonvissuto
May 31, 2022
Researchers have secured close to a total of $35 million across multiple U.S. studies to identify falls prevention strategies and risk factors for cognitive decline, as well as expand a dementia-specific...
Senior living operator aims to raise ‘Purple Flag’ across its memory care communities
By
Kimberly Bonvissuto
May 01, 2023
A New England-based assisted living provider is the first in the nation to seek dementia care accreditation for its entire portfolio of memory care communities through Purple Flag for Dementia Care.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Senior living residents contribute to understanding of aging through pilot studies despite pandemic challenges
By
Kimberly Bonvissuto
Dec 14, 2020
Senior living residents are furthering the understanding of aging through pilot programs in their communities even while they cope with the effects of a global pandemic.